Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Update

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the target of a significant decrease in short interest in July. As of July 31st, there was short interest totaling 325 shares, a decrease of 57.0% from the July 15th total of 756 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 4,595 shares, the days-to-cover ratio is presently 0.1 days.

Fidelity Disruptive Medicine ETF Price Performance

Fidelity Disruptive Medicine ETF stock traded up $0.10 during mid-day trading on Friday, reaching $30.22. 2,085 shares of the company were exchanged, compared to its average volume of 11,199. The company has a fifty day simple moving average of $28.16 and a 200-day simple moving average of $26.26. Fidelity Disruptive Medicine ETF has a 12 month low of $23.48 and a 12 month high of $30.54. The firm has a market cap of $48.35 million, a PE ratio of 41.33 and a beta of 0.75.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of FMED. Jane Street Group LLC raised its stake in Fidelity Disruptive Medicine ETF by 95.4% in the fourth quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock valued at $2,473,000 after purchasing an additional 44,630 shares in the last quarter. Vise Technologies Inc. acquired a new stake in Fidelity Disruptive Medicine ETF during the fourth quarter worth about $234,000. Finally, Virtu Financial LLC bought a new position in Fidelity Disruptive Medicine ETF in the 4th quarter valued at about $228,000.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.